Stemline Therapeutics

750 Lexington Ave
11th Floor
New York,  NY  10022

United States
http://www.stemline.com
  • Booth: 17159

Stemline is clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk. Stemline is developing three clinical stage product candidates, SL-401, SL-701, and SL-801. Exhibit Display will include disease information on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), and details on ongoing clinical trials for our 3 pipeline products.


  •  
  •      
     

  •  
  •